UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 26, 2010
CELANESE CORPORATION
(Exact name of registrant as specified in its charter)
         
DELAWARE   001-32410   98-0420726
(State or other jurisdiction of
incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
1601 West LBJ Freeway, Dallas, Texas 75234-6034
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code:  (972) 443-4000
Not Applicable
(Former name or former address, if changed since last report):
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 7.01 Regulation FD Disclosure.
On September 15, 2010, Celanese US Holdings LLC (the “Issuer”), a wholly-owned subsidiary of Celanese Corporation (the “Parent Guarantor”), issued $600 million of senior notes due 2018 (the “Notes”) pursuant to an exemption from registration under the Securities Act of 1933, as amended (the “Securities Act”). The Notes are guaranteed by the Parent Guarantor and substantially all of its US subsidiaries (the “Subsidiary Guarantors”). Under the indenture, dated September 24, 2010, between the Issuer and Wells Fargo Bank, N.A. as trustee (the “Indenture”), the Issuer is required to provide to the Securities and Exchange Commission (“SEC”) certain financial information described in Rule 3-10 of Regulation S-X promulgated under the Securities Act. In connection with this reporting requirement, the consolidating financial statements for the Parent Guarantor, the Issuer, the Subsidiary Guarantors and the non-guarantors are being furnished as Exhibit 99.1 to this Current Report on Form 8-K (“Form 8-K”) and are incorporated herein by reference in their entirety.
The information in this Item 7.01 of this Form 8-K should be read in conjunction with the Parent Guarantor’s Quarterly Report on Form 10-Q filed with the SEC on October 26, 2010.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
     
Exhibit Number   Description
99.1
  Consolidated Financial Statements for Parent Guarantor*
 
*   In connection with the disclosure set forth in Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
SIGNATURES
          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
 

Celanese Corporation
 
 
  By:   /s/ James R. Peacock III    
    Name:   James R. Peacock III   
    Title:   Vice President, Deputy General Counsel and Assistant Corporate Secretary   
 
Date: October 26, 2010

 


 

Exhibit Index
     
Exhibit Number   Description
99.1
  Consolidated Financial Statements for Parent Guarantor*
 
*   In connection with the disclosure set forth in Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.

 

Exhibit 99.1
Consolidating Guarantor Financial Information
On September 24, 2010, the Company completed the issuance of senior unsecured notes (the “Notes”) by Celanese US (the “Issuer”). The Notes are guaranteed by Celanese Corporation (the “Parent Guarantor”) and substantially all of its US subsidiaries (the “Subsidiary Guarantors”). The consolidating financial statements for the Parent Guarantor, the Issuer, the Subsidiary Guarantors and the non-guarantors are as follows:
CELANESE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
                                                 
    Three Months Ended September 30, 2010  
    Parent             Subsidiary     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
                    (In $ millions)                  
Net sales
                600       1,164       (258 )     1,506  
Cost of sales
                (416 )     (989 )     245       (1,160 )
 
                                   
Gross profit
                184       175       (13 )     346  
Selling, general and administrative expenses
                (38 )     (85 )           (123 )
Amortization of intangible assets
                (4 )     (11 )           (15 )
Research and development expenses
                (13 )     (6 )           (19 )
Other (charges) gains, net
                41       (5 )           36  
Foreign exchange gain (loss), net
                      (1 )           (1 )
Gain (loss) on disposition of businesses and assets, net
                (1 )     (2 )           (3 )
 
                                   
Operating profit
                169       65       (13 )     221  
Equity in net earnings (loss) of affiliates
    153       194       43       28       (381 )     37  
Interest expense
          (41 )     (10 )     (11 )     14       (48 )
Interest income
          5       8       1       (14 )      
Refinancing expense
          (16 )                       (16 )
Dividend income — cost investments
                      1             1  
Other income (expense), net
                      (4 )           (4 )
 
                                   
Earnings (loss) from continuing operations before tax
    153       142       210       80       (394 )     191  
Income tax (provision) benefit
    (1 )     11       (37 )     (23 )     6       (44 )
 
                                   
Earnings (loss) from continuing operations
    152       153       173       57       (388 )     147  
 
                                   
Earnings (loss) from operation of discontinued operations
                (1 )     (2 )           (3 )
Gain (loss) on disposal of discontinued operations
                                   
Income tax (provision) benefit from discontinued operations
                      1             1  
 
                                   
Earnings (loss) from discontinued operations
                (1 )     (1 )           (2 )
 
                                   
Net earnings (loss)
    152       153       172       56       (388 )     145  
Net (earnings) loss attributable to noncontrolling interests
                                   
 
                                   
Net earnings (loss) attributable to Celanese Corporation
    152       153       172       56       (388 )     145  
 
                                   

 


 

CELANESE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
                                                 
    Nine Months Ended September 30, 2010  
    Parent             Subsidiary     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
                    (In $ millions)                  
Net sales
                1,703       3,401       (693 )     4,411  
Cost of sales
                (1,281 )     (2,958 )     695       (3,544 )
 
                                   
Gross profit
                422       443       2       867  
Selling, general and administrative expenses
                (126 )     (243 )           (369 )
Amortization of intangible assets
                (10 )     (35 )           (45 )
Research and development expenses
                (35 )     (21 )           (56 )
Other (charges) gains, net
                51       (98 )           (47 )
Foreign exchange gain (loss), net
                      1             1  
Gain (loss) on disposition of businesses and assets, net
                (1 )     13             12  
 
                                   
Operating profit
                301       60       2       363  
Equity in net earnings (loss) of affiliates
    297       392       109       97       (764 )     131  
Interest expense
          (121 )     (29 )     (34 )     38       (146 )
Interest income
          16       21       4       (39 )     2  
Refinancing expense
          (16 )                       (16 )
Dividend income — cost investments
                      73             73  
Other income (expense), net
                (1 )     2             1  
 
                                   
Earnings (loss) from continuing operations before tax
    297       271       401       202       (763 )     408  
Income tax (provision) benefit
    (1 )     26       (82 )     (50 )     22       (85 )
 
                                   
Earnings (loss) from continuing operations
    296       297       319       152       (741 )     323  
 
                                   
Earnings (loss) from operation of discontinued operations
                (6 )     (2 )           (8 )
Gain (loss) on disposal of discontinued operations
                2                   2  
Income tax (provision) benefit from discontinued operations
                1       1             2  
 
                                   
Earnings (loss) from discontinued operations
                (3 )     (1 )           (4 )
 
                                   
Net earnings (loss)
    296       297       316       151       (741 )     319  
Net (earnings) loss attributable to noncontrolling interests
                                   
 
                                   
Net earnings (loss) attributable to Celanese Corporation
    296       297       316       151       (741 )     319  
 
                                   

 


 

CELANESE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
                                                 
    Three Months Ended September 30, 2009  
    Parent             Subsidiary     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
                    (In $ millions)                  
Net sales
                513       1,021       (230 )     1,304  
Cost of sales
                (363 )     (907 )     232       (1,038 )
 
                                   
Gross profit
                150       114       2       266  
Selling, general and administrative expenses
                (46 )     (64 )           (110 )
Amortization of intangible assets
                (2 )     (18 )           (20 )
Research and development expenses
                (10 )     (8 )           (18 )
Other (charges) gains, net
                (1 )     (95 )           (96 )
Foreign exchange gain (loss), net
                      (2 )           (2 )
Gain (loss) on disposition of businesses and assets, net
                18       25       2       45  
 
                                   
Operating profit
                109       (48 )     4       65  
Equity in net earnings (loss) of affiliates
    379       355       21       29       (748 )     36  
Interest expense
          (43 )     (10 )     (11 )     13       (51 )
Interest income
          6       7       2       (13 )     2  
Refinancing expense
                                   
Dividend income — cost investments
                      1             1  
Other income (expense), net
          1       (1 )     (5 )           (5 )
 
                                   
Earnings (loss) from continuing operations before tax
    379       319       126       (32 )     (744 )     48  
Income tax (provision) benefit
    15       60       296       (20 )     (1 )     350  
 
                                   
Earnings (loss) from continuing operations
    394       379       422       (52 )     (745 )     398  
 
                                   
Earnings (loss) from operation of discontinued operations
                                   
Gain (loss) on disposal of discontinued operations
                                   
Income tax (provision) benefit from discontinued operations
                                   
 
                                   
Earnings (loss) from discontinued operations
                                   
 
                                   
Net earnings (loss)
    394       379       422       (52 )     (745 )     398  
Net (earnings) loss attributable to noncontrolling interests
                                   
 
                                   
Net earnings (loss) attributable to Celanese Corporation
    394       379       422       (52 )     (745 )     398  
 
                                   

 


 

CELANESE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
                                                 
    Nine Months Ended September 30, 2009  
    Parent             Subsidiary     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
                    (In $ millions)                  
Net sales
                1,507       2,892       (705 )     3,694  
Cost of sales
                (1,081 )     (2,604 )     705       (2,980 )
 
                                   
Gross profit
                426       288             714  
Selling, general and administrative expenses
                (139 )     (199 )           (338 )
Amortization of intangible assets
                (8 )     (50 )           (58 )
Research and development expenses
                (33 )     (23 )           (56 )
Other (charges) gains, net
                (4 )     (119 )           (123 )
Foreign exchange gain (loss), net
                      1             1  
Gain (loss) on disposition of businesses and assets, net
                7       25       9       41  
 
                                   
Operating profit
                249       (77 )     9       181  
Equity in net earnings (loss) of affiliates
    469       510       63       60       (1,025 )     77  
Interest expense
          (128 )     (34 )     (35 )     41       (156 )
Interest income
          19       21       9       (42 )     7  
Refinancing expense
                                   
Dividend income — cost investments
                38       19             57  
Other income (expense), net
          4       (2 )     (4 )           (2 )
 
                                   
Earnings (loss) from continuing operations before tax
    469       405       335       (28 )     (1,017 )     164  
Income tax (provision) benefit
    15       64       276       (26 )     (1 )     328  
 
                                   
Earnings (loss) from continuing operations
    484       469       611       (54 )     (1,018 )     492  
 
                                   
Earnings (loss) from operation of discontinued operations
                                   
Gain (loss) on disposal of discontinued operations
                                   
Income tax (provision) benefit from discontinued operations
                                   
 
                                   
Earnings (loss) from discontinued operations
                                   
 
                                   
Net earnings (loss)
    484       469       611       (54 )     (1,018 )     492  
Net (earnings) loss attributable to noncontrolling interests
                                   
 
                                   
Net earnings (loss) attributable to Celanese Corporation
    484       469       611       (54 )     (1,018 )     492  
 
                                   

 


 

CELANESE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
                                                 
    As of September 30, 2010  
    Parent             Subsidiary     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
    (In $ millions)  
ASSETS
                                               
Current assets
                                               
Cash and cash equivalents
    3             255       626             884  
Trade receivables — third party and affiliates
                255       743       (101 )     897  
Non-trade receivables
          544       653       386       (1,319 )     264  
Inventories
                163       460       (45 )     578  
Deferred income taxes
                33       10       (1 )     42  
Marketable securities, at fair value
                1       1             2  
Assets held for sale
                9                   9  
Other assets
          57       30       68       (64 )     91  
 
                                   
Total current assets
    3       601       1,399       2,294       (1,530 )     2,767  
 
                                   
Investments in affiliates
    908       3,704       1,360       518       (5,673 )     817  
Property, plant and equipment, net
                623       2,261             2,884  
Deferred income taxes
    12       36       380       71             499  
Marketable securities, at fair value
                79                   79  
Other assets
          76       121       516       (421 )     292  
Goodwill
                298       487             785  
Intangible assets, net
                83       188             271  
 
                                   
Total assets
    923       4,417       4,343       6,335       (7,624 )     8,394  
 
                                   
LIABILITIES AND SHAREHOLDERS’ EQUITY
                                               
Current liabilities
                                               
Short-term borrowings and current installments of long-term debt — third party and affiliates
          1,191       17       224       (1,171 )     261  
Trade payables — third party and affiliates
          2       232       507       (101 )     640  
Other liabilities
          76       225       524       (236 )     589  
Deferred income taxes
                (6 )     39             33  
Income taxes payable
    3       (323 )     323       120       (9 )     114  
 
                                   
Total current liabilities
    3       946       791       1,414       (1,517 )     1,637  
 
                                   
Long-term debt
          2,510       561       354       (415 )     3,010  
Deferred income taxes
                      132             132  
Uncertain tax positions
    3       17       36       210             266  
Benefit obligations
                1,148       109             1,257  
Other liabilities
          36       146       1,009       (16 )     1,175  
Total Celanese Corporation shareholders’ equity
    917       908       1,661       3,107       (5,676 )     917  
Noncontrolling interests
                                   
 
                                   
Total shareholders’ equity
    917       908       1,661       3,107       (5,676 )     917  
 
                                   
Total liabilities and shareholders’ equity
    923       4,417       4,343       6,335       (7,624 )     8,394  
 
                                   

 


 

CELANESE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
                                                 
    As of December 31, 2009  
    Parent             Subsidiary     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
    (In $ millions)  
ASSETS
                                               
Current assets
                                               
Cash and cash equivalents
    5             520       729             1,254  
Trade receivables — third party and affiliates
                274       602       (155 )     721  
Non-trade receivables
          13       774       335       (860 )     262  
Inventories
                148       415       (41 )     522  
Deferred income taxes
                32       11       (1 )     42  
Marketable securities, at fair value
                2       1             3  
Assets held for sale
                      2             2  
Other assets
          12       25       59       (46 )     50  
 
                                   
Total current assets
    5       25       1,775       2,154       (1,103 )     2,856  
 
                                   
Investments in affiliates
    574       3,282       1,316       465       (4,845 )     792  
Property, plant and equipment, net
                634       2,163             2,797  
Deferred income taxes
    12       40       375       57             484  
Marketable securities, at fair value
                80                   80  
Other assets
          614       133       533       (969 )     311  
Goodwill
                284       514             798  
Intangible assets, net
                60       234             294  
 
                                   
Total assets
    591       3,961       4,657       6,120       (6,917 )     8,412  
 
                                   
LIABILITIES AND SHAREHOLDERS’ EQUITY
                                               
Current liabilities
                                               
Short-term borrowings and current installments of long-term debt — third party and affiliates
          768       16       197       (739 )     242  
Trade payables — third party and affiliates
                261       543       (155 )     649  
Other liabilities
          98       209       465       (161 )     611  
Deferred income taxes
                (6 )     39             33  
Income taxes payable
    3       (297 )     284       86       (4 )     72  
 
                                   
Total current liabilities
    3       569       764       1,330       (1,059 )     1,607  
 
                                   
Long-term debt
          2,756       1,109       358       (964 )     3,259  
Deferred income taxes
                      137             137  
Uncertain tax positions
    2       18       19       190             229  
Benefit obligations
                1,167       121             1,288  
Other liabilities
          44       176       1,105       (19 )     1,306  
Total Celanese Corporation shareholders’ equity
    586       574       1,422       2,879       (4,875 )     586  
Noncontrolling interests
                                   
 
                                   
Total shareholders’ equity
    586       574       1,422       2,879       (4,875 )     586  
 
                                   
Total liabilities and shareholders’ equity
    591       3,961       4,657       6,120       (6,917 )     8,412  
 
                                   

 


 

CELANESE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                 
    Nine Months Ended September 30, 2010  
    Parent                     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
    (In $ millions)  
Net cash provided by (used in) operating activities
    1       242       (140 )     260             363  
Investing activities from continuing operations
                                               
Capital expenditures on property, plant and equipment
                (51 )     (71 )           (122 )
Acquisitions, net of cash acquired
                (46 )                 (46 )
Proceeds from sale of businesses and assets, net
                1       21             22  
Capital expenditures related to Ticona Kelsterbach plant relocation
                      (219 )           (219 )
Other, net
                (6 )     (10 )           (16 )
 
                                   
Net cash provided by (used in) investing activities
                (102 )     (279 )           (381 )
Financing activities from continuing operations
                                               
Short-term borrowings (repayments), net
                2       (6 )           (4 )
Proceeds from long-term debt
          604       33             (37 )     600  
Repayments of long-term debt
          (822 )     (5 )     (58 )     37       (848 )
Refinancing costs
          (24 )                       (24 )
Purchases of treasury stock, including related fees
    (41 )                             (41 )
Dividends from subsidiary
    53                       (53 )      
Dividends to parent
                (53 )           53        
Stock option exercises
    8                               8  
Series A common stock dividends
    (20 )                             (20 )
Preferred stock dividends
    (3 )                             (3 )
 
                                   
Net cash provided by (used in) financing activities
    (3 )     (242 )     (23 )     (64 )           (332 )
Exchange rate effects on cash and cash equivalents
                      (20 )             (20 )
 
                                   
Net increase (decrease) in cash and cash equivalents
    (2 )           (265 )     (103 )           (370 )
Cash and cash equivalents at beginning of period
    5             520       729             1,254  
 
                                   
Cash and cash equivalents at end of period
    3             255       626             884  
 
                                   

 


 

CELANESE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                 
    Nine Months Ended September 30, 2009  
    Parent                     Non-              
    Guarantor     Issuer     Guarantors     Guarantors     Eliminations     Consolidated  
    (In $ millions)  
Net cash provided by (used in) operating activities
          20       167       221             408  
Investing activities from continuing operations
                                               
Capital expenditures on property, plant and equipment
                (41 )     (89 )           (130 )
Acquisitions, net of cash acquired
                      (1 )           (1 )
Proceeds from sale of businesses and assets, net
                131       37             168  
Deferred proceeds on Ticona Kelsterbach plant relocation
                      412             412  
Capital expenditures related to Ticona Kelsterbach plant relocation
                      (248 )           (248 )
Proceeds from sale of marketable securities
                      15             15  
Other, net
                5       (30 )           (25 )
 
                                   
Net cash provided by (used in) investing activities
                95       96             191  
Financing activities from continuing operations
                                               
Short-term borrowings (repayments), net
                (8 )     39             31  
Proceeds from long-term debt
          4                   (4 )      
Repayments of long-term debt
          (21 )     (19 )     (20 )     4       (56 )
Refinancing costs
          (3 )                       (3 )
Dividends from subsidiary
    24                         (24 )      
Dividends to parent
                (24 )           24        
Stock option exercises
    1                               1  
Series A common stock dividends
    (17 )                             (17 )
Preferred stock dividends
    (8 )                             (8 )
 
                                   
Net cash provided by (used in) financing activities
          (20 )     (51 )     19             (52 )
Exchange rate effects on cash and cash equivalents
                      70             70  
 
                                   
Net increase (decrease) in cash and cash equivalents
                211       406             617  
Cash and cash equivalents at beginning of period
                224       452             676  
 
                                   
Cash and cash equivalents at end of period
                435       858             1,293